Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07636590 · ClinicalTrials.gov registry record
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A clinical trial, sponsored by Claris Biotherapeutics.
- Recruiting
- Registry status
- 500
- Enrollment target
NCT07636590 is a clinical trial that is actively recruiting participants, run by Claris Biotherapeutics. The registered enrollment target is 500 participants.
The verdict
NCT07636590 is actively recruiting participants, sponsored by Claris Biotherapeutics.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-05-22 |
| Est. Completion | 2028-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07636590
The ClinicalTrials.gov registry entry for NCT07636590 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Claris Biotherapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT07636590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07636590 about?
NCT07636590 is a clinical study titled "Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency". The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
What is the current status of trial NCT07636590?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-05-22. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07636590?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT07636590?
This trial is sponsored by Claris Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.